Viewing

Cataract & Refractive

Latest News


CME Content


Implantation of an intracorneal inlay (Kamra, AcuFocus) modified the normal structure of the corneal layer of the eye but did not cause severe complications in a recent small study.

Both toric IOLs and peripheral corneal relaxing incisions (PCRIs) reduce astigmatism, but toric IOLs do so to a greater extent as well as being more predictable, according to results of a recently published study.

One solution for presbyopes is small diameter corneal inlays and in this article Dr Ratkay-Traub discusses her study into the long-term outcomes of presbyopia treatment with a hydrogel near vision inlay.

Predicting the position of an iris-fixated pIOL is important to ensure intraocular structure health is maintained. In this article, Dr Soltani Moghadam describes his recent study that found AS-OCT imaging technique to be particularly useful as a preoperative simulation technique.

Corneal anterior segment imaging has emerged as a screening tool for refractive surgery, cataract and glaucoma. In this article, the authors discuss their recent study that identified a set of normative data to correct for sources of bias in pre-surgery screening.

In this article, Dr Cervino discusses how his recent study examining the quality of anterior segment images obtained with posterior segment OCT devices is good enough to obtain repeatable measures of anterior segment parameters manually using external analysis software.

The microbiological spectrum in patients with post-traumatic endophthalmitis has remained unchanged over the past 14 years, with Bacillus spp. still the most commonly found infecting organism, and vancomycin remaining the drug of choice for empiric coverage of gram-positive bacteria.

The Optimis Fusion integrated laser platform from Quantel Medical has received CE Mark approval. The system is a combination of advanced selective laser trabeculoplasty photoregeneration therapy with traditional YAG photodisruption treatment for treating both cataract and glaucoma.

Corneal refractive surgery may be more successful in eyes in which the cylinder mainly originates from the anterior cornea; therefore, in candidates for refractive surgery, surgeons should carefully assess the interaction between topographic, refractive and ocular residual astigmatism (ORA) to identify those at high risk for having significant differences between subjective cylinder and topographic astigmatism.

Comparing phaco tips

Phaco tips are an important part of the phacoemulsification tool set. Dr Bazzigaluppi performed a comparison on a traditional and newer tip to evaluate the efficiency, safety and stability differences. Here, we explore his reasons for performing this study.

In this article, Dr Akpek discusses the pros and cons of currently available options in the management of meibomian gland dysfunction.

Post-refractive surgery dry eye is an unwanted yet reoccurring problem for surgeons, according to Dr Cummings. In this article, he discusses the pre-op approach taken in his practice, which leads to a more certain diagnosis and higher patient satisfaction rates.

Replacing monovision

The availability of newer presbyopia solutions such as corneal inlays has changed the landscape of presbyopia treatment and is now allowing us to offer our patients a better quality of vision.

Meeting Review

Ophthalmologists from 76 countries discussed the latest findings in diagnostics and therapy, and also issues of promoting the next generation of young ophthalmologists.

Advancements in cataract surgery have always been surrounded by passionate debate with arguments for and against new technologies and techniques. In this article, the authors discuss their recent study in which they examined the evolution of cataract surgery and controversy surrounding it.

Nicox has launched Sjö, an advanced diagnostic panel for the early detection of Sjögren's syndrome, and has formed a partnership with the Sjögren's Syndrome Foundation to raise aware of this disease among eye care professionals.

ML7 has the potential to bring an effective, targeted therapeutic response in patients who suffer from dry eye syndromes. Preclinical trials of the eye-drop formulation of Neuroptis Biotech's ML7 product have yielded positive results, and have recently been published.